MedPath

Ninlaro

Brand Name: Ninlaro

Generic Name: Ixazomib (as citrate)

Active
Registration Number

DR-XY46356

Dosage Form

Capsule

Issuance Date

April 20, 2023

Expiry Date

April 20, 2028

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength4 mg
PackagingPVC-Alu/Alu Blister sealed inside a Wallet Pack containing one Capsule. Three single Blister Wallet Packs are packaged in one Carton.

Classification

C
Classification
Prescription Drug (RX)
A
Application
Monitored Release (Variation)
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Ixazomib (as citrate)Active
Monograph: Ixazomib

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform